SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  SCHEDULE 13G
                                 (Rule 13d-102)


             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
                            PURSUANT TO RULE 13d-2(b)

                               (Amendment No. 3)



                         Curative Health Services, Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)



                          Common Stock, $0.01 Par Value
--------------------------------------------------------------------------------
                         (Title of Class of Securities)



                                    231264102
--------------------------------------------------------------------------------
                                 (CUSIP Number)


                                December 31, 2003
--------------------------------------------------------------------------------
             (Date of Event Which Requires Filing of this Statement)


     Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

          [_] Rule 13d-1(b)

          [X] Rule 13d-1(c)

          [_] Rule 13d-1(d)


----------
(1)  The remainder of this cover page shall be filled out for a reporting
     person's initial filing on this form with respect to the subject class of
     securities, and for any subsequent amendment containing information which
     would alter the disclosures provided in a prior cover page.

     The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).



CUSIP No.   231264102


1.   NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     Basil P. Regan

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a) [_]
                                                                 (b) [X]

3.   SEC USE ONLY


4.   CITIZENSHIP OR PLACE OF ORGANIZATION

     United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.   SOLE VOTING POWER

        0

6.   SHARED VOTING POWER

        0

7.   SOLE DISPOSITIVE POWER

        0

8.   SHARED DISPOSITIVE POWER

        0

9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        0

10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

                                                                      [_]

11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

        0%

12.  TYPE OF REPORTING PERSON*

        IN

--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!



CUSIP No.   231264102


Item 1(a).  Name of Issuer:

                          Curative Health Systems, Inc.
            --------------------------------------------------------------------

Item 1(b).  Address of Issuer's Principal Executive Offices:

                               150 Motor Parkway
                               Hauppauge, NY 11788
            --------------------------------------------------------------------

Item 2(a-c).  Name of Person Filing, Address of Principal Business Office,
              or if None, Residence, Citizenship

                               Basil P. Regan
                               c/o Regan Partners, L.P.
                               32 East 57th Street, 20th Floor
                               NY, NY  10022
            --------------------------------------------------------------------

                               United States of America
            --------------------------------------------------------------------

Item 2(d).  Title of Class of Securities:

                               Common Stock, $0.01 Par Value
            --------------------------------------------------------------------

Item 2(e).  CUSIP Number:

            231264102

Item 3.     If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
            or (c), Check Whether the Person Filing is a:

     (a)    [_] Broker or dealer registered under Section 15 of the Exchange
                Act.

     (b)    [_] Bank as defined in Section 3(a)(6) of the Exchange Act.

     (c)    [_] Insurance company as defined in Section 3(a)(19) of the
                Exchange Act.

     (d)    [_] Investment company registered under Section 8 of the
                Investment Company Act.

     (e)    [_] An investment adviser in accordance with Rule
                13d-1(b)(1)(ii)(E);

     (f)    [_] An employee benefit plan or endowment fund in accordance with
                Rule 13d-1(b)(1)(ii)(F);

     (g)    [_] A parent holding company or control person in accordance with
                Rule 13d-1(b)(1)(ii)(G);

     (h)    [_] A savings association as defined in Section 3(b) of the
                Federal Deposit Insurance Act;

     (i)    [_] A church plan that is excluded from the definition of an
                investment company under Section 3(c)(14) of the Investment
                Company Act;

     (j)    [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

Item 4.     Ownership.

     Provide  the  following  information  regarding  the  aggregate  number and
percentage of the class of securities of the issuer identified in Item 1.

     (a)    Amount beneficially owned:

                                    0 shares*
            --------------------------------------------------------------------

     (b)    Percent of class:

                                    0%
            --------------------------------------------------------------------

     (c)    Number of shares as to which such person has:

            (i)  Sole power to vote or to direct the vote
                                                                        0,
                                                                ----------------

          (ii)  Shared power to vote or to direct the vote
                                                                        0,
                                                                ----------------

          (iii) Sole power to dispose or to direct the
                disposition of                                          0,
                                                                ----------------

          (iv)  Shared power to dispose or to direct the
                disposition of                                          0.
                                                                ----------------

Item 5.     Ownership of Five Percent or Less of a Class.

     If this  statement  is being  filed to report  the fact that as of the date
hereof the reporting  person has ceased to be the beneficial  owner of more than
five percent of the class of securities check the following [X].

Item 6.     Ownership of More Than Five Percent on Behalf of Another Person.

     If any other  person is known to have the right to  receive or the power to
direct the receipt of dividends  from,  or the  proceeds  from the sale of, such
securities,  a statement  to that effect  should be included in response to this
item and, if such interest relates to more than five percent of the class,  such
person  should be  identified.  A listing of the  shareholders  of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.

                                       N/A
            --------------------------------------------------------------------

Item 7.     Identification and Classification of the Subsidiary Which Acquired
            the Security Being Reported on by the Parent Holding Company or
            Control Person.

     If a parent  holding  company  or Control  person has filed this  schedule,
pursuant to Rule  13d-1(b)(1)(ii)(G),  so indicate under Item 3(g) and attach an
exhibit  stating the  identity  and the Item 3  classification  of the  relevant
subsidiary.  If a parent  holding  company  or  control  person  has filed  this
schedule  pursuant to Rule 13d-1(c) or Rule 13d-1(d),  attach an exhibit stating
the identification of the relevant subsidiary.

                                       N/A
            --------------------------------------------------------------------

Item 8.     Identification  and  Classification  of Members of the Group.

     If a group has filed this schedule  pursuant to  ss.240.13d-1(b)(1)(ii)(J),
so indicate under Item 3(j) and attach an exhibit  stating the identity and Item
3 classification of each member of the group. If a group has filed this schedule
pursuant to  ss.240.13d-1(c) or  ss.240.13d-1(d),  attach an exhibit stating the
identity of each member of the group.

                                       N/A
            --------------------------------------------------------------------

Item 9.     Notice of Dissolution of Group.

     Notice of dissolution of a group may be furnished as an exhibit stating the
date  of  the   dissolution  and  that  all  further  filings  with  respect  to
transactions in the security reported on will be filed, if required,  by members
of the group, in their individual capacity. See Item 5.

                                       N/A
            --------------------------------------------------------------------

Item 10.    Certifications.

     (a)    The following certification shall be included if the statement is
            filed pursuant to Rule 13d-1(b):

            "By  signing  below  I  certify  that,  to  the  best  of my
            knowledge and belief, the securities  referred to above were
            acquired and are held in the ordinary course of business and
            were not  acquired  and not held for the  purpose of or with
            the effect of  changing  or  influencing  the control of the
            issuer of the  securities  and were not acquired and are not
            held  in  connection   with  or  as  a  participant  in  any
            transaction having such purpose or effect."

     (b)    The following certification shall be included if the statement is
            filed pursuant to Rule 13d-1(c):

            "By  signing  below  I  certify  that,  to  the  best  of my
            knowledge and belief, the securities  referred to above were
            not acquired and are not held for the purpose of or with the
            effect of changing or influencing  the control of the issuer
            of the  securities and were not acquired and are not held in
            connection  with  or as a  participant  in  any  transaction
            having such purpose or effect."


                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.



                                                   February 1, 2004
                                        ----------------------------------------
                                                        (Date)



                                                  /s/ Basil P. Regan*
                                        ----------------------------------------
                                                      (Signature)


                                                      Basil P. Regan*
                                        ----------------------------------------
                                                      (Name/Title)



Note.  Schedules  filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
for whom copies are to be sent.

Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).

*It is noted that the Reporting Person disclaims his beneficial ownership in the
securities reported herein except to the extent of this pecuniary interest.


01394.0001 #460449